An interventional study of Nutritional counseling in Cardiovascular Diseases, Schizophrenia and Psychosis, sponsored by Vestre Viken Hospital Trust. Recruiting at 2 sites in Norway. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-01-09.
Sponsored by Vestre Viken Hospital Trust · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The goal of this clinical trial is to compare the effect of nutritional counseling versus no treatment in patients with schizophenia or bipolar affective disorder.
The main question it aims to answer are:
Participants will meet a nutritionist at baseline to asess nutritional status, biochemical and anthropometric measurements. Then, half of the study population will receive nutritional counseling. After six weeks, the same baseline measurements will be repeated to examine any potential differences between the two groups. After the intervention, the control group will be offered the same counseling as the intervention group received during the study.
People with severe mental illness have a shorter life expectancy compared to the general population. Individuals with schizophrenia or bipolar affective disorder have an estimated reduce life expectancy by an average of 10-20 years. Increased mortality is caused by many factors, but cardiovascular diseases contributes the most. Increased prevalence of cardiovascular disease is mainly due to a poor lifestyle, which includes smoking, physical inactivity and an unhealthy diet.
It is important to find treatment that can provide better quality of life and longer life expectancy in these patient groups. Few clinical studies have been conducted on the effect of nutritional counseling on biochemical and anthropometric measurements related to cardiovascular diseases. Therefore, we want to investigate this through a randomized controlled trial.
5,376 studies on the registry are indexed under Cardiovascular Diseases; 940 are open to participants now.
This study's planned enrollment of 40 is below the median of 100 across 3,086 interventional studies indexed under Cardiovascular Diseases.
Browse Cardiovascular Diseases studies →Vestre Viken Hospital Trust is the lead sponsor of 52 studies on the registry; 23 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The intervention group will recieve 30 x 2 minutes with nutritonal counseling seperatet by a 15 minutes break. The participants will receive individually tailored guidance based on the information recieved at baseline measurments. The couseling will be based on the Norwegian goverments dietary advices and the recommendation from the Directorate of Health for the prevention of cardiovascular diseases.
Non-HDL cholesterol
HDL-cholesterol - total cholesterol, biochemical test
Time frame: 6 weeks
total cholesterol
biochemical test
Time frame: 6 weeks
HDL-cholesterol
biochemical test
Time frame: 6 weeks
Triglycerids
biochemical test
Time frame: 6 weeks
HbA1c
biochemical test
Time frame: 6 weeks
ALT AST/ALT AST/ALT
biochemical test
Time frame: 6 weeks
fasting glucose
biochemical test
Time frame: 6 weeks
Vitamin D
biochemical test
Time frame: 6 weeks
Folate
biochemical test
Time frame: 6 weeks
LDL-cholesterol
biochemical test
Time frame: 6 weeks
Weight
anthropometric measurement
Time frame: 6 weeks
waist circumference
anthropometric measurement
Time frame: 6 weeks
Bloodpressure
Time frame: 6 weeks
24-hour dietary recall
interview
Time frame: 6 weeks
Food frequency questionnaire
questionnaire
Time frame: 6 weeks
Plan to share: No — The IPD will be stored at TSD- services for sensitive data. Only researchers in this prosject will have acsess
No publications or documents are linked to this record.
Started Sep 2023 (actual). Primary completion is estimated for May 2024, 7 months after the start.
Of 1,081 non-industry interventional studies with no phase under Cardiovascular Diseases, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 48. This study's planned 7 months is below that.
Counting every sponsor, half of 1,220 studies reached it within 26 months; a quarter within 12 and three quarters within 49.
Cardiovascular Diseases covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Vestre Viken Hospital Trust